Prevention, diagnosis, and treatment of influenza: Current and future options

Current Opinion in Pediatrics

Volumn 13, Issue 1, 2001, Pages 60-64

  Poehling, Katherine A ^a,b   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE; ZANAMIVIR;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; CHILD; DIAGNOSTIC TEST; DRUG INDICATION; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; NEUROTOXICITY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; VIRUS CULTURE;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE; NUCLEIC ACID SYNTHESIS INHIBITORS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0035136326     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200102000-00011     Document Type: Review

References (45)

1. Influenza surveillance in community-dwelling elderly compared with children
2. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
3. The impact of winter epidemics of influenza and respiratory syncytial virus on paediatric admissions to an urban general hospital
4. Influenza and the rates of hospitalization for respiratory disease among infants and young children
5. Impact of respiratory virus infections on persons with chronic underlying conditions
6. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices
7. Current and future use of vaccines for viral and bacterial respiratory tract infections
8. Influenza
9. Influenza
10. Influenza and respiratory syncytial virus: Update on infection, management, and prevention
11. Influenza
12. Update: Influenza activity-United States and worldwide, 1999-2000 season, and composition of the 2000-2001 influenza vaccine
13. The importance of global surveillance of influenza
14. Effect of prednisone on response to influenza virus vaccine in asthmatic children
15. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy
16. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma, vaccine safety datalink team
17. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease
18. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasa, influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
19. The efficacy of live attenuated, cold adapted, trivalent, intranasal influenzavirus vaccine in children
20. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children
21. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
22. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA Test) and cell culture methods
23. Antiviral agents for treating influenza
24. Getting a jump on flu: New options in diagnosis and treatment
25. Influenza virus neuraminidase inhibitors
26. Neuraminidase inhibitors for treatment of influenza A and B infections
27. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
28. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial
29. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial
30. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
31. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: A randomized controlled trial
32. Oseltamivir
33. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults
34. Zanamivir: A review of clinical safety
35. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir
36. Use of oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment
37. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
38. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
39. Coadministration of orally inhaled zanamavir with inactivated trivalent influenza vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers
40. Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
41. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus
42. Potential cost savings attributable to influenza vaccination of school-aged children